Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

[Prevalence of potential drug-drug interactions involving antiretroviral drugs in Buenos Aires, Argentina].

Córdova E, Porteiro N, Loiza E, Mingrone H.

Rev Chilena Infectol. 2016 Oct;33(Suppl 1):54-59. doi: 10.4067/S0716-10182016000700006. Spanish.

2.

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fätkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, Klingman KL, Collins S, Lane HC, Phillips AN, Neaton JD.

N Engl J Med. 2015 Aug 27;373(9):795-807. doi: 10.1056/NEJMoa1506816. Epub 2015 Jul 20.

3.

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial.

INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, Lundgren J, Babiker A, Gordin F, Emery S, Fätkenheuer G, Molina JM, Wood R, Neaton JD.

HIV Med. 2015 Apr;16 Suppl 1:1-9. doi: 10.1111/hiv.12227. No abstract available.

4.

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study.

Cahn P, Pozniak AL, Mingrone H, Shuldyakov A, Brites C, Andrade-Villanueva JF, Richmond G, Buendia CB, Fourie J, Ramgopal M, Hagins D, Felizarta F, Madruga J, Reuter T, Newman T, Small CB, Lombaard J, Grinsztejn B, Dorey D, Underwood M, Griffith S, Min S; extended SAILING Study Team.

Lancet. 2013 Aug 24;382(9893):700-8. doi: 10.1016/S0140-6736(13)61221-0. Epub 2013 Jul 3. Erratum in: Lancet. 2014 Jan 4;383(9911):30.

PMID:
23830355
5.

Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN).

Sang CN, Sathyanarayana R, Sweeney M; DM-1796 Study Investigators.

Clin J Pain. 2013 Apr;29(4):281-8. doi: 10.1097/AJP.0b013e318258993e.

PMID:
22801243
6.

Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters.

Socías ME, Sued O, Laufer N, Lázaro ME, Mingrone H, Pryluka D, Remondegui C, Figueroa MI, Cesar C, Gun A, Turk G, Bouzas MB, Kavasery R, Krolewiecki A, Pérez H, Salomón H, Cahn P; Grupo Argentino de Seroconversión Study Group.

J Int AIDS Soc. 2011 Aug 10;14:40. doi: 10.1186/1758-2652-14-40.

7.

Predicted susceptibility of etravirine in HIV patients experiencing virological failure secondary to non-nucleoside reverse transcriptase inhibitor resistance in Argentina.

Córdova E, Loiza E, Porteiro N, Mingrone H.

Enferm Infecc Microbiol Clin. 2011 Jun-Jul;29(6):428-31. doi: 10.1016/j.eimc.2011.03.003. Epub 2011 May 17.

PMID:
21592625
8.

Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection.

Cooper DA, Heera J, Goodrich J, Tawadrous M, Saag M, Dejesus E, Clumeck N, Walmsley S, Ting N, Coakley E, Reeves JD, Reyes-Teran G, Westby M, Van Der Ryst E, Ive P, Mohapi L, Mingrone H, Horban A, Hackman F, Sullivan J, Mayer H.

J Infect Dis. 2010 Mar 15;201(6):803-13. doi: 10.1086/650697.

PMID:
20151839
9.

Similar safety and efficacy of once- and twice-daily lopinavir/ritonavir tablets in treatment-experienced HIV-1-infected subjects at 48 weeks.

Zajdenverg R, Podsadecki TJ, Badal-Faesen S, Andrade-Villanueva J, Gathe J, Mingrone H, Fredrick LM, Gaultier IA, Woodward WC, Bernstein BM.

J Acquir Immune Defic Syndr. 2010 Jun;54(2):143-51. doi: 10.1097/QAI.0b013e3181cbd21e.

PMID:
20134330
10.

Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia.

Salvarezza CR, Mingrone H, Fachinelli H, Kijanczuk S.

J Antimicrob Chemother. 1998 Mar;41 Suppl B:75-80.

PMID:
9579717
11.

[Primary bronchial actinomycosis and foreign body].

Mingrone H, Perrone R, La Rosa S, Schtirbu R, Lutzky L.

Medicina (B Aires). 1995;55(4):337-40. Review. Spanish.

PMID:
8728875

Supplemental Content

Loading ...
Support Center